Lead Sponsor

Chinese University of Hong Kong

Collaborators

Age

All ages

Sex

FEMALE

Healthy Volunteers

Yes

•Women who had undergone standard mammography including craniocaudal (CC) and mediolateral oblique (MLO) views..
•Histopathology-proven diagnosis is available for patients with breast malignancy, including invasive breast cancer, carcinoma in situ, and borderline lesion et al.
•As reference standard of benign nature, results from pathology or clinical long-term follow-up (\>=2 years) examinations are available for cases without breast malignancy.

•Patients with concurring lesions on mammograms that may influence subsequent AI post-process.
•Patients without available pathologic diagnosis or long-term follow-up (\>=2 years) examinations.
•Patients who had undergone breast surgical intervention (e.g. lumpectomy and mammoplasty) prior to first mammography.
•Patients diagnosed with other kinds of malignancy, concurrent with metastasis or infiltration/invasion to breast.